Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
HSS Journal ®
Published in: HSS Journal ® 1/2018

01-02-2018 | Original Article

Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients

Authors: Anne R. Bass, MD, Jackie D. Szymonifka, MA, Matthew T. Rondina, MD, MS, Margaret Bogardus, BA, Mitchell G. Scott, PhD, Scott C. Woller, MD, Scott M. Stevens, MD, Charles Eby, MD, Kerri Merritt, BA, Alejandro Gonzalez Della Valle, MD, Gerard Moskowitz, PhD, Eva Flores, MD, Brian F. Gage, MD, MSc

Published in: HSS Journal ® | Issue 1/2018

Login to get access

Abstract

Background

Orthopedic patients are at risk for adverse postoperative cardiovascular outcomes.

Questions/Purposes

This pilot randomized controlled trial (RCT) of atorvastatin vs. placebo in orthopedic surgery patients was performed in order to assess: (1) the prevalence of perioperative myocardial injury; (2) the effect of atorvastatin on perioperative inflammation; and (3) the feasibility of performing a large RCT of statin therapy in orthopedic patients.

Methods

Hip fracture (hip Fx) and total hip and knee replacement (THR and TKR) patients were randomized 1:1 to atorvastatin 40 mg daily vs. placebo, starting preoperatively and continuing until postoperative day (POD) 45. High-sensitivity cardiac troponin I (hs-cTnI), high-sensitivity C-reactive protein (hs-CRP), and interleukin-6 (IL-6) were measured preoperatively and on POD 2. Patients were monitored for adverse events until POD 90.

Results

Five hundred fifty-six patients were screened, 22 were recruited (4 hip Fx, 11 THR, 7 TKR), and 2 withdrew. Most (80%) had detectable hs-cTnI (> 1.1 pg/mL) preoperatively. Twenty percent had a perioperative rise in hs-cTnI (≥ 10 pg/mL), which was not blunted by atorvastatin. Hs-CRP rose in 19/20 patients, and IL-6 rose in all patients. However, atorvastatin did not blunt the rise in these inflammatory biomarkers. On POD 2, IL-6 and hs-cTnI levels correlated (ρ = 0.59, p = 0.02). Recruitment was limited by the high prevalence of statin use in the screened population and a high prevalence of exclusions among hip fracture patients.

Conclusion

Perioperative myocardial injury and inflammation are common in orthopedic patients and do not appear to be reduced in those randomized to atorvastatin.

Trial Registration

NCT02197065
Appendix
Available only for authorised users
Literature
1.
Albayati MA, Grover SP, Saha P, Lwaleed BA, Modarai B, Smith A. Postsurgical inflammation as a causative mechanism of venous thromboembolism. Semin Thromb Hemost. 2015;41:615–20.
2.
Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012;58:1574–81.CrossRefPubMed
3.
Bass AR, Rodriguez T, Hyun G, Santiago FG, Kim JI, Woller SC, et al. Myocardial ischaemia after hip and knee arthroplasty: incidence and risk factors. Int Orthop. 2015;39:2011–6.
4.
Beloosesky Y, Hendel D, Weiss A, Hershkovitz A, Grinblat J, Pirotsky A, et al. Cytokines and C-reactive protein production in hip-fracture-operated elderly patients. J Gerontol A Biol Sci Med Sci. 2007;62:420–6.
5.
Bemenderfer TB, Rozario NL, Moore CG, Karunakar MA. Morbidity and mortality in elective total hip arthroplasty following surgical care improvement project guidelines. J Arthroplasty. 2017;32(8):2359–2362.CrossRefPubMed
6.
Berwanger O, Le Manach Y, Suzumura EA, Biccard B, Srinathan SK, Szczeklik W, et al. Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study. Eur Heart J. 2016;37:177–85.
7.
Bjornsson GL, Thorsteinsson L, Gudmundsson KO, Jonsson H,Jr, Gudmundsson S, Gudbjornsson B. Inflammatory cytokines in relation to adrenal response following total hip replacement. Scand J Immunol. 2007;65:99–105.CrossRefPubMed
8.
Cavender MA, White WB, Jarolim P, Bakris GL, Cushman WC, Kupfer S, et al. Serial measurement of high sensitivity troponin I and cardiovascular outcomes in patients with type 2 diabetes mellitus in the EXAMINE Trial. Circulation. 2017;135(20):1911–1921.
9.
Chloropoulou P, Iatrou C, Vogiatzaki T, Kotsianidis I, Trypsianis G, Tsigalou C, et al. Epidural anesthesia followed by epidural analgesia produces less inflammatory response than spinal anesthesia followed by intravenous morphine analgesia in patients with total knee arthroplasty. Med Sci Monit. 2013;19:73–80.
10.
Durazzo AE, Machado FS, Ikeoka DT, De Bernoche C, Monachini MC, Puech-Leao P, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39:967,75; discussion 975-6.
11.
Ekeloef S, Alamili M, Devereaux PJ, Gogenur I. Troponin elevations after non-cardiac, non-vascular surgery are predictive of major adverse cardiac events and mortality: a systematic review and meta-analysis. Br J Anaesth. 2016;117:559–68.CrossRefPubMed
12.
Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR,Jr. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem. 1997;43:1749–56.PubMed
13.
Gaudilliere B, Fragiadakis GK, Bruggner RV, Nicolau M, Finck R, Tingle M, et al. Clinical recovery from surgery correlates with single-cell immune signatures. Sci Transl Med. 2014;6:255ra131.
14.
Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM,Jr, Kastelein JJ, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009;360:1851–61.
15.
Hietala P, Strandberg M, Kiviniemi T, Strandberg N, Airaksinen KE. Usefulness of troponin T to predict short-term and long-term mortality in patients after hip fracture. Am J Cardiol. 2014;114:193–7.CrossRefPubMed
16.
Hijazi Z, Aulin J, Andersson U, Alexander JH, Gersh B, Granger CB, et al. Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation. Heart. 2016;102:508–17.
17.
Jameson SS, Kyle J, Baker PN, Mason J, Deehan DJ, McMurtry IA, et al. Patient and implant survival following 4323 total hip replacements for acute femoral neck fracture: a retrospective cohort study using National Joint Registry data. J Bone Joint Surg Br. 2012;94:1557–66.
18.
Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol. 2005;175:3463–8.CrossRefPubMed
19.
Jules-Elysee KM, Lipnitsky JY, Patel N, Anastasian G, Wilfred SE, Urban MK, Sculco TP. Use of low-dose steroids in decreasing cytokine release during bilateral total knee replacement. Reg Anesth Pain Med. 2011;36:36–40.CrossRefPubMed
20.
Juliebo V, Krogseth M, Skovlund E, Engedal K, Wyller TB. Medical treatment predicts mortality after hip fracture. J Gerontol A Biol Sci Med Sci. 2010;65:442–9.CrossRefPubMed
21.
Lalmohamed A, Vestergaard P, de Boer A, Leufkens HG, van Staa TP, de Vries F. Changes in mortality patterns following total hip or knee arthroplasty over the past two decades: a nationwide cohort study. Arthritis Rheumatol. 2014;66:311–8.CrossRefPubMed
22.
Lalmohamed A, Vestergaard P, Klop C, Grove EL, de Boer A, Leufkens HG, et al. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study. Arch Intern Med. 2012;172(16):1229–35.
23.
Lapidus LJ, Ponzer S, Pettersson H, de Bri E. Symptomatic venous thromboembolism and mortality in orthopaedic surgery—an observational study of 45 968 consecutive procedures. BMC Musculoskelet Disord. 2013;14:177.CrossRefPubMedPubMedCentral
24.
Le Manach Y, Collins G, Bhandari M, Bessissow A, Boddaert J, Khiami F, et al. Outcomes after hip fracture surgery compared with elective total hip replacement. JAMA. 2015;314:1159–66.
25.
Lindahl B, Venge P, James S. The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. Am Heart J. 2010;160:224–9.CrossRefPubMed
26.
London MJ, Schwartz GG, Hur K, Henderson WG. Association of perioperative statin use with mortality and morbidity after major noncardiac surgery. JAMA Intern Med. 2017;177:231–42.CrossRefPubMed
27.
Lu N, Misra D, Neogi T, Choi HK, Zhang Y. Total joint arthroplasty and the risk of myocardial infarction: a general population, propensity score-matched cohort study. Arthritis Rheumatol. 2015;67:2771–9.CrossRefPubMedPubMedCentral
28.
Martins TB, Pasi BM, Litwin CM, Hill HR. Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum. Clin Diagn Lab Immunol. 2004;11:325–9.PubMedPubMedCentral
29.
Martins TB, Pasi BM, Pickering JW, Jaskowski TD, Litwin CM, Hill HR. Determination of cytokine responses using a multiplexed fluorescent microsphere immunoassay. Am J Clin Pathol. 2002;118:346–53.CrossRefPubMed
30.
Memtsoudis SG, Gonzalez Della Valle A, Besculides MC, Gaber L, Sculco TP. In-hospital complications and mortality of unilateral, bilateral, and revision TKA: based on an estimate of 4,159,661 discharges. Clin Orthop Relat Res. 2008;466:2617–27.CrossRefPubMedPubMedCentral
31.
Nagele P, Brown F, Gage BF, Gibson DW, Miller JP, Jaffe AS, et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. Am Heart J. 2013;166:325,332.e1.
32.
33.
Oberweis BS, Smilowitz NR, Nukala S, Rosenberg A, Xu J, Stuchin S, et al. Relation of perioperative elevation of troponin to long-term mortality after orthopedic surgery. Am J Cardiol. 2015;115:1643–8.
34.
Pesic G, Jeremic J, Nikolic T, Zivkovic V, Srejovic I, Vranic A, et al. Interleukin-6 as possible early marker of stress response after femoral fracture. Mol Cell Biochem. 2017;430(1–2):191–199.
35.
Peters SA, Palmer MK, Grobbee DE, Crouse JR, 3rd, O'Leary DH, Raichlen JS, et al. C-reactive protein lowering with rosuvastatin in the METEOR study. J Intern Med. 2010;268:155–61.
36.
Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014;349:g4829.
37.
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM,Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–207.
38.
Rodriguez AL, Wojcik BM, Wrobleski SK, Myers DD, Jr, Wakefield TW, Diaz JA. Statins, inflammation and deep vein thrombosis: a systematic review. J Thromb Thrombolysis. 2012;33:371–82.CrossRefPubMedPubMedCentral
39.
Sandoval Y, Smith SW, Apple FS. Present and future of cardiac troponin in clinical practice: a paradigm shift to high-sensitivity assays. Am J Med. 2016;129:354–65.CrossRefPubMed
40.
Scandinavian 4S. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–9.
41.
Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813:878–88.
42.
Schouten O, Boersma E, Hoeks SE, Benner R, van Urk H, van Sambeek MR, et al. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361:980–9.
43.
Shah K, Mohammed A, Patil S, McFadyen A, Meek RMD. Circulating cytokines after hip and knee arthroplasty: a preliminary study. Clin Orthop Relat Res. 2009;467:946–51.CrossRefPubMed
44.
Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301–7.
45.
46.
Sun T, Wang X, Liu Z, Chen X, Zhang J. Plasma concentrations of pro- and anti-inflammatory cytokines and outcome prediction in elderly hip fracture patients. Injury. 2011;42:707–13.CrossRefPubMed
47.
Vallet H, Breining A, Le Manach Y, Cohen-Bittan J, Meziere A, Raux M, et al. Isolated cardiac troponin rise does not modify the prognosis in elderly patients with hip fracture. Medicine (Baltimore). 2017;96:e6169.
48.
Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators, Devereaux PJ, Chan MT, Alonso-Coello P, Walsh M, Berwanger O, Villar JC, Wang CY, Garutti RI, Jacka MJ, Sigamani A, Srinathan S, Biccard BM, Chow CK, Abraham V, Tiboni M, Pettit S, Szczeklik W, Lurati Buse G, Botto F, Guyatt G, Heels-Ansdell D, Sessler DI, Thorlund K, Garg AX, Mrkobrada M, Thomas S, Rodseth RN, Pearse RM, Thabane L, McQueen MJ, VanHelder T, Bhandari M, Bosch J, Kurz A, Polanczyk C, Malaga G, Nagele P, Le Manach Y, Leuwer M, Yusuf S. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307:2295–304.CrossRef
49.
Wadia SK, Belkin M, Chow KS, Nattiv J, Appis A, Feinstein SB, et al. In-hospital statin underutilization among high-risk patients: delayed uptake of the 2013 cholesterol guidelines in a U.S. cohort. Hosp Pract (1995). 2017;45:16–20.
50.
Winchester DE, Wen X, Xie L, Bavry AA. Evidence of pre-procedural statin therapy a meta-analysis of randomized trials. J Am Coll Cardiol. 2010;56:1099–109.CrossRefPubMed
51.
Wu AH, Shea E, Lu QT, Minyard J, Bui K, Hsu JC, et al. Short- and long-term cardiac troponin I analyte stability in plasma and serum from healthy volunteers by use of an ultrasensitive, single-molecule counting assay. Clin Chem. 2009;55:2057–9.
Metadata
Title
Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients
Authors
Anne R. Bass, MD
Jackie D. Szymonifka, MA
Matthew T. Rondina, MD, MS
Margaret Bogardus, BA
Mitchell G. Scott, PhD
Scott C. Woller, MD
Scott M. Stevens, MD
Charles Eby, MD
Kerri Merritt, BA
Alejandro Gonzalez Della Valle, MD
Gerard Moskowitz, PhD
Eva Flores, MD
Brian F. Gage, MD, MSc
Publication date
01-02-2018
Publisher
Springer US
Published in
HSS Journal ® / Issue 1/2018
Print ISSN: 1556-3316
Electronic ISSN: 1556-3324
DOI
https://doi.org/10.1007/s11420-017-9577-1

Other articles of this Issue 1/2018

HSS Journal ® 1/2018 Go to the issue

Original Article

Shoulder Arthroplasty for Humeral Head Avascular Necrosis Is Associated With Increased Postoperative Complications

Original Article

Long Head of Biceps Tendon Management: a Survey of the American Shoulder and Elbow Surgeons

Original Article

Epidemiology and Disease Burden of Lateral Epicondylitis in the USA: Analysis of 85,318 Patients

Review Article

Clavicle Malunions: Surgical Treatment and Outcome—a Literature Review

Original Article

Outcomes Following Operative Treatment of Adolescent Mallet Fractures

Original Article

The Infection Rate of Metal-on-Metal Total Hip Replacement Is Higher When Compared to Other Bearing Surfaces as Documented by the Australian Orthopaedic Association National Joint Replacement Registry